Evaluation of Apelin and Apelin Receptor Level in the Primary Tumor and Serum of Colorectal Cancer Patients

Colorectal cancer is the second deadliest tumor, which has a positive correlation with obesity which led to increasing interest in the relationship between adipokines and cancer progression. Apelin is a secreted peptide involved in regulation of tumor progression and invasiveness. In this study, we examined apelin and apelin receptor expression level in colorectal cancer. Apelin, and its receptor mRNA, and protein expression levels were measured in tumor tissue of 56 surgically treated colorectal adenocarcinoma (CRC) patients. We also analyzed apelin and apelin receptor protein levels in sera of 56 CRC patients and 27 healthy controls. The mRNA and protein level of this peptide and its receptor was higher in tumors than that in control tissue. Serum levels of apelin and apelin receptor were increased in CRC patients in comparison to controls. The concentration of serum apelin level significantly increased in individuals with lymph node and distant metastasis. Obtained results suggest that apelin could be an important factor in progression of colorectal carcinoma.

[1]  S. Dabernat,et al.  Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells , 2019, Molecular oncology.

[2]  Zheng Zhang,et al.  High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer , 2019, Disease markers.

[3]  M. Aktan,et al.  A Preliminary Study of Serum Apelin Levels in Patients with Head and Neck Cancer. , 2019, The Eurasian journal of medicine.

[4]  J. Rosińćzuk,et al.  Assessment of apelin, apelin receptor, resistin, and adiponectin levels in the primary tumor and serum of patients with esophageal squamous cell carcinoma. , 2019, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[5]  G. Khan,et al.  Colorectal Cancer and Nutrition , 2019, Nutrients.

[6]  Katarzyna Pietraszek-Gremplewicz,et al.  Apelin Effects Migration and Invasion Abilities of Colon Cancer Cells , 2018, Cells.

[7]  G. Norčič.  Liquid Biopsy in Colorectal Cancer-Current Status and Potential Clinical Applications , 2018, Micromachines.

[8]  Katarzyna Pietraszek-Gremplewicz,et al.  The Role of Apelin in Cardiovascular Diseases, Obesity and Cancer , 2018, Front. Physiol..

[9]  N. Yoo,et al.  Expressional analysis of APLNR, an essential gene for cancer immunotherapy, in colon and prostate cancers. , 2018, Pathology, research and practice.

[10]  R. Glen,et al.  Pharmacological targeting of apelin impairs glioblastoma growth , 2017, Brain : a journal of neurology.

[11]  M. Ebert,et al.  Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer , 2017, Oncotarget.

[12]  E. Fiedor,et al.  Bisphenol A and its derivatives tetrabromobisphenol A and tetrachlorobisphenol A induce apelin expression and secretion in ovarian cancer cells through a peroxisome proliferator-activated receptor gamma-dependent mechanism. , 2017, Toxicology letters.

[13]  S. Glaser,et al.  Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth. , 2017, Cancer letters.

[14]  G. Pamuk,et al.  High apelin levels could be used as a diagnostic marker in multiple myeloma: A comparative study. , 2017, Cancer biomarkers : section A of Disease markers.

[15]  M. Akyol,et al.  Serum apelin levels and body composition changes in breast cancer patients treated with an aromatase inhibitor. , 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[16]  Hongwei Yu,et al.  Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer , 2016, BMC Cancer.

[17]  F. Jiang,et al.  Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer. , 2015, Human pathology.

[18]  D. Dupré,et al.  The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR. , 2014, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[19]  K. Grabowski,et al.  Serum Levels of Resistin, Adiponectin, and Apelin in Gastroesophageal Cancer Patients , 2014, Disease markers.

[20]  F. Guadagni,et al.  Obesity and colorectal cancer: role of adipokines in tumor initiation and progression. , 2014, World journal of gastroenterology.

[21]  J. Tímár,et al.  Apelin Expression in Human Non-small Cell Lung Cancer: Role in Angiogenesis and Prognosis , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  F. Heppner,et al.  Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. , 2007, Developmental biology.

[23]  C. Bing,et al.  Adipose tissue and adipokines--energy regulation from the human perspective. , 2006, The Journal of nutrition.

[24]  I. Castan-Laurell,et al.  Apelin, a newly identified adipokine up-regulated by insulin and obesity. , 2005, Endocrinology.

[25]  A. De Luca,et al.  Apelin expression in normal human tissues. , 2002, In vivo.

[26]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[27]  S. Hinuma,et al.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. , 1998, Biochemical and biophysical research communications.

[28]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .